A randomised,prospective and unblinded manner clinical trial to compare the effect of inhaled budesonide suspension with budesonide nebuliseron severity of postoperative sorethroat subsequent to endotracheal intubation

Pt B D Sharma University of Health Sciences PGIMS, Rohtak, Haryana0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: O- Medical and Surgical

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: O- Medical and Surgical
Sponsor: Pt B D Sharma University of Health Sciences PGIMS, Rohtak, Haryana
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Investigators

Sponsor

Pt B D Sharma University of Health Sciences PGIMS, Rohtak, Haryana

Eligibility Criteria

Inclusion Criteria

•Patients belonging to ASA 1\-2 with MPG 1\-2 undergoing surgery under general anaesthesia

Exclusion Criteria

•Patients with anticipated difficult airway, history of allergy to test drug,active preoperative sore throat,analgesics and corticosteroids in treatment regime,history of fluid retention, history of delayed wound healing, history of glucose intolerance,laparoscopic surgeries ,duration of surgery \< 60min or \>180min, refusal to participate in the study will be excluded from the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting

Not Applicable

Prospective, randomized, subject single-blind, double-arm study to evaluate the outcome of ADM without basement membrane in prosthetic breast reconstructio

KCT0005852Asan Medical Center60

Active, not recruiting

Not Applicable

An randomized, controlled, investigator-blinded, prospective, mono-centre study to evaluate the efficacy of fosfomycin versus meropenem in patients with complicated urinary tract infections - urosepsis/fosfo vs. meropenemThis study will primarily address the question of the efficacy of intravenous fosfomycin 4 g b.i.d. in the therapy of patients presenting with complicated urinary tract infection. These data will be compared to meropenem administered intravenously at a dose of 2 g b.i.d.MedDRA version: 9.1Level: LLTClassification code 10046571Term: Urinary tract infection

EUCTR2007-005112-37-ATMedizinische Universität Wien, Abteilung für Interne Medizin I240

Active, not recruiting

Phase 1

Safety, tolerability and efficacy study of CLL442 in patients with Cutaneous Squamous Cell Carcinoma in situ (SCCis).

EUCTR2017-003495-31-BEovartis Pharma AG40

Active, not recruiting

Phase 1

Study of LIK066 in overweight and obese women with polycystic ovary syndromepolycystic ovary syndromeMedDRA version: 20.0Level: LLTClassification code 10036050Term: Polycystic ovarySystem Organ Class: 100000004872Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]

EUCTR2017-001373-16-DEovartis Pharma AG29

Active, not recruiting

Phase 1

Study of safety, tolerability, pharmacokinetics and pharmacodynamics of QBW251 in subjects with bronchiectasisBronchiectasisMedDRA version: 23.0Level: LLTClassification code 10083611Term: Non-cystic fibrosis bronchiectasisSystem Organ Class: 100000004855Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]

EUCTR2019-002840-26-DEovartis Pharma AG72